The results suggested that highly expressed ADAM12 correlated with the activation of pathways such as SCLC, pathway in cancer, transforming growth factor beta signaling pathway, while lowly expressed ADAM12 associated with the metabolism pathway such as butanoate metabolism, fatty acid metabolism, histidine metabolism (Fig. 6A). Here, ADAM12 is linked to small cell lung carcinoma.